← Back to Search

Exercise Training for Mental Illness

N/A
Recruiting
Led By Ryan Garten, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Apparently healthy and free of overt cardiovascular, pulmonary, or metabolic disease
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to the end of the final visit, about 14 weeks
Awards & highlights

Study Summary

This trial will test the effects of different types of exercise on blood vessel function in people with and without mental health disorders.

Who is the study for?
This trial is for healthy individuals and those with PTSD or GAD who have specific scores on mental health scales. It's not for pregnant women, current/recent smokers, people with limited English proficiency, those on certain cardiovascular meds, drug/alcohol users, or anyone on a significant calorie restriction.Check my eligibility
What is being tested?
The study is testing the effects of two types of exercise training—muscular fitness and strength training—on blood vessel function in both healthy participants and those with PTSD or GAD.See study design
What are the potential side effects?
While the trial involves exercise interventions that are generally safe, potential side effects may include muscle soreness, fatigue, joint pain or injury from physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am healthy with no obvious heart, lung, or metabolic diseases.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to the end of the final visit, about 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to the end of the final visit, about 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Arm Vascular Function at Rest (Flow Mediated Dilation Test)
Arm Vascular Function in Response to Exercise (Handgrip Exercise Test)
Leg Vascular Function (Passive Leg Movement Test)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Muscular fitnessExperimental Treatment1 Intervention
Participants will complete study 1 (HM20020955-1) and then 10 weeks of resistance training for muscular fitness
Group II: Muscular StrengthExperimental Treatment1 Intervention
Participants will complete study 1 (HM20020955-1) and then 10 weeks of resistance training for muscular strength

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
699 Previous Clinical Trials
22,884,805 Total Patients Enrolled
Ryan Garten, PhDPrincipal InvestigatorVirginia Commonwealth University
5 Previous Clinical Trials
1,187 Total Patients Enrolled

Media Library

Muscular Fitness Training Group Clinical Trial Eligibility Overview. Trial Name: NCT04916340 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any slots still available to join this research endeavor?

"The data on clinicaltrials.gov reveals that this medical experiment is actively searching for volunteers, with the original post dating to January 24th and a recent edit occurring August 1st."

Answered by AI

How many participants have joined this research endeavor?

"Affirmative. Details available through clinicaltrials.gov confirm that this medical study, which was first announced on January 24th 2022, is actively recruiting individuals for participation. The trial intends to enrol 240 patients from a single location."

Answered by AI

What patient demographics are most suitable for this research project?

"This clinical study seeks to recruit 240 individuals aged 18-35 who are suffering from peripheral vascular diseases. To meet the eligibility criteria, healthy control candidates must have a score of 10 or lower on the GAD-7 self-report scale and 33 or below on the PCL-5 checklist; for those with Generalized Anxiety Disorder (GAD), scores should be above 10 and below 33 respectively; participants in both groups must apparently be free from cardiovascular, pulmonary, or metabolic illnesses; PTSD patients need to register at least 33 on the PCL-5 questionnaire."

Answered by AI

Does this investigation have an upper-age limit for participants?

"This clinical trial demands that qualified patients are aged 18 to 35. On the other hand, there are 120 separate trials specifically designed for those under 18 and an additional 508 studies intended for people over 65 years old."

Answered by AI
~37 spots leftby Oct 2024